Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study

C Then, HL Then, A Lechner, B Thorand, C Meisinger… - Atherosclerosis, 2020 - Elsevier
Background and aims Serum uromodulin, a novel biomarker of kidney function and tubular
integrity, has been linked to cardiovascular events and total mortality in patients at high
cardiovascular risk. Here, we analyze the association of serum uromodulin with
cardiovascular morbidity and cardiovascular as well as total mortality in the population-
based KORA F4 study stratified by sex. Methods Baseline serum uromodulin was measured
in 1079 participants of the KORA F4 study (age 62–81 years). Using multivariable adjusted …